Lindsey Pimentel
Family · Brandon, FLNPI 1528585734
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,130 and has fallen 70.7% since, to $331 in 2025.
Across 118 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$295
- Lilly USA, LLC$277
- Novo Nordisk$242
- Johnson & Johnson$183
- Abbott$178
- AstraZeneca$169
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,608100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 4 | $295 |
| Lilly USA, LLC | 24 | $277 |
| Novo Nordisk | 9 | $242 |
| Johnson & Johnson(3 entities) | 14 | $183 |
| Abbott | 4 | $178 |
| AstraZeneca | 9 | $169 |
| Boston Scientific | 1 | $146 |
| Merck | 7 | $126 |
| Eisai Inc. | 2 | $94 |
| Sanofi | 4 | $94 |
| Nevro Corp. | 1 | $93 |
| Boehringer Ingelheim | 5 | $84 |
| AbbVie(2 entities) | 3 | $56 |
| Biohaven Pharmaceuticals, Inc. | 3 | $55 |
| Exelixis Inc. | 3 | $53 |
| Redhill Biopharma Inc. | 3 | $53 |
| Genmab U.S., Inc. | 2 | $45 |
| Adaptive Biotechnologies Corporation | 2 | $42 |
| Acera Surgical, Inc. | 2 | $37 |
| Amgen(2 entities) | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| Medtronic | 1 | $19 |
| Pharmaessentia USA Corporation | 1 | $19 |
| Bayer | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $17 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| Masimo Corporation | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $13 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$146
- FreeStyle Libre 2$132
- Ozempic$114
How this compares
$2,608 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Brandon
- Loretta ZanettiBrandon$42K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.